ResMed Inc.RMDNYSE
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+17.6%
5Y CAGR+14.1%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+17.6%/yr
vs +14.7%/yr prior
5Y CAGR
+14.1%/yr
Recent acceleration
Acceleration
+2.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.91B | +24.8% |
| 2024 | $1.53B | +12.9% |
| 2023 | $1.36B | +15.5% |
| 2022 | $1.18B | +6.6% |
| 2021 | $1.10B | +11.5% |
| 2020 | $990.43M | +40.3% |
| 2019 | $705.80M | +3.8% |
| 2018 | $680.22M | +19.6% |
| 2017 | $568.89M | +8.8% |
| 2016 | $522.72M | - |